Drugs Online |
 |
 | ||
|
Exermet P 515 Actosplus Met |
|
| ||
Drugs Online » Prescription Drugs 7 » Exermet P 515 Actosplus Met Treating type 2 diabetes. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicines.Metformin/Pioglitazone is a biguanide and thiazolidinedione antidiabetic combination. It works by decreasing the amount of sugar the liver produces and the intestines absorb. It also helps to make your body more sensitive to the insulin that you naturally produce.Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are already treated with pioglitazone plus metformin or whose diabetes is not adequately controlled with metformin alone or for those patients who initially responded to pioglitazone alone and require additional glycemic control. Buy Exermet P 515 Actosplus Met and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About Exermet P 515 Actosplus Met: Product Type: Prescription Drugs 7 Exermet P (515) ( Actosplus Met Generic Pioglitazone & Metformin ) Exermet P (515 Actosplus Met Generic Pioglitazone & Metformin) 515 Actosplus Met Generic Pioglitazone & Metformin 15mg/500mg 180 Tablets 90 Tabs 515 Actosplus Met Generic Pioglitazone & Metformin Exermet P
View more Prescription Drugs 7 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
